Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 21:12:720049.
doi: 10.3389/fimmu.2021.720049. eCollection 2021.

Roles of Inflammasome in Cigarette Smoke-Related Diseases and Physiopathological Disorders: Mechanisms and Therapeutic Opportunities

Affiliations
Review

Roles of Inflammasome in Cigarette Smoke-Related Diseases and Physiopathological Disorders: Mechanisms and Therapeutic Opportunities

Yiming Ma et al. Front Immunol. .

Abstract

Cigarette smoke damages a wide range of immunological functions, including innate and adaptive immune responses. Emerging literature demonstrates that inflammasome constitutes an essential component in innate immune response. In this review, we focus on the cumulative mechanisms of inflammasome in cigarette smoke-related diseases and physiopathological disorders, and summarize potential therapeutic opportunities targeting inflammasome. This review suggests that inflammasomes (NLRP3, NLRP6, NLRP12 and AIM2) are involved in the pathogenesis of several cigarette smoke-related diseases (including COPD, ALI, atherosclerosis, kidney injury, bladder dysfunction, and oral leukoplakia) and physiopathological disorders (macrophage dysfunction, endothelial barrier dysfunction, podocyte injury, and ubiquitin-mediated proteasomal processing). MyD88/NF-κB, HMGB1, production of ROS, endoplasmic reticulum stress and mitochondrial dysfunction, and Ca2+ influx are potentially involved in cigarette smoke induced-inflammasome activation. Strategies targeting ROS/NLRP3 inflammasome axis are most widely investigated and show potential therapeutic effects.

Keywords: NLRP3; ROS; cigarette smoke; inflammasome; innate immune.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, et al. . Smoking Prevalence and Cigarette Consumption in 187 Countries, 1980-2012. Jama-J Am Med Assoc (2014) 311(2):183–92. 10.1001/jama.2013.284692 - DOI - PubMed
    1. Ambrose JA, Barua RS. The Pathophysiology of Cigarette C-V Smoking and Cardiovascular Disease - An Update. J Am Coll Cardiol (2004) 43(10):1731–7. 10.1016/j.jacc.2003.12.047 - DOI - PubMed
    1. Yoshida T, Tuder RM. Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease. Physiol Rev (2007) 87(3):1047–82. 10.1152/physrev.00048.2006 - DOI - PubMed
    1. Pope CA III, Burnett RT, Turner MC, Cohen A, Krewski D, Jerrett M, et al. . Lung Cancer and Cardiovascular Disease Mortality Associated With Ambient Air Pollution and Cigarette Smoke: Shape of the Exposure-Response Relationships. Environ Health Perspect (2011) 119(11):1616–21. 10.1289/ehp.1103639 - DOI - PMC - PubMed
    1. Huxley RR, Woodward M. Cigarette Smoking as a Risk Factor for Coronary Heart Disease in Women Compared With Men: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Lancet (2011) 378(9799):1297–305. 10.1016/s0140-6736(11)60781-2 - DOI - PubMed

Publication types